Clinical benefit of metagenomic sequencing for complicated infectious disease

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035501

Enrollment

Unknown

Registered

2020-08-13

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-tuberculosis mycobacteria infection

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-80 years; 2. More than 1 NTM positive culturing result; 3. Histology shows evidence of NTM infection.

Exclusion criteria

Exclusion criteria: 1. Unqualified samples; 2. Unqualified sequencing QC; 3. Patients with severe mental illness or cognitive dysfunction; 4. Subjects who could not cope with clinical observation and sample collection due to poor compliance.

Design outcomes

Primary

Measure	Time frame
recurrent rate of 3 years;responsive rate of treatment;	—

Secondary

Measure	Time frame
drug resistant rate;	—

Contacts

Public ContactQing Miao

Shanghai Zhongshan Hospital

sadsadvenus@163.com+86 13601621604

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026